Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival

Clinical and Experimental Allergy

Volumn 33, Issue 8, 2003, Pages 1135-1140

  Moller C ^a   Xiang, Z ^a   Nilsson, Gunnar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

A1; Adenosine; Akt; Apoptosis; Asthma; De granulation; Fc RI; IgE; Mast cells; Survival

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ANTIGEN; BETA N ACETYLHEXOSAMINIDASE; I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTHMA; BONE MARROW CELL; CELL ACTIVATION; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; GENE EXPRESSION; GENE FUNCTION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SURVIVAL RATE;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; APOPTOSIS; BETA-N-ACETYLHEXOSAMINIDASE; BONE MARROW CELLS; CELL DEGRANULATION; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; MAST CELLS; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IGE; RECEPTORS, PURINERGIC P1; REPLICATION PROTEIN C; UP-REGULATION;

EID: 0042622577     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01728.x     Document Type: Article

References (37)

1. Williams CMM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105:847-59.
2. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000; 30(Suppl. 1):28-32.
3. Kobayasi T, Asboe-Hansen G. Degranulation and regranulation of human mast cells. Acta Derm Venerol 1969; 49:369-81.
4. Dvorak AM, Schleimer RP, Lichtenstein LM. Morphologic mast cell cycles. Cell Immunol 1987; 105:199-204.
5. Xiang Z, Block M, Löfman C, Nilsson G. IgE-mediated mast cell degranulation and recovery monitored by time-lapse photography. J Allergy Clin Immunol 2001; 108:116-21.
6. Xiang Z, Ahmed AA, Möller C, Nakayama K-i, Hatakeyama S, Nilsson G. Essential role of the pro-survival bc-2 homolog A1 in mast cell survival following allergic activation. J Exp Med 2001; 194:1561-9.
7. Forsythe P, Ennis M. Adenosine, mast cells and asthma. Inflamm Res 1999; 48:301-7.
8. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15:161-5.
9. Prieto L, Gutierrez V, Linana J, Marin J. Bronchoconstriction induced by inhaled adenosine 5′-monophosphate in subjects with allergic rhinitis. Eur Respir J 2001; 17:64-70.
10. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61:1667-76.
11. Rafferty P, Beasley R, Southgate P, Holgate S. The role of histamine in allergen and adenosine-induced bronchoconstriction. Int Arch Allergy Appl Immunol 1987; 82:292-4.
12. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988; 138:1143-51.
13. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci (London) 1999; 96:349-55.
14. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41:775-87.
15. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 1994; 15:298-306.
16. Meade CJ, Mierau J, Leon I, Ensinger HA. In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells. J Pharmacol Exp Ther 1996; 279:1148-56.
17. Auchampach JA, Jin X, Wan TC, Caughey GH, Linden J. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol 1997; 52:846-60.
18. Pauwels RA, Joos GF. Characterization of the adenosine receptors in the airways. Arch Int Pharmacodyn Ther 1995; 329:151-60.
19. Nyce JW, Metzger WJ. DNA antisense therapy for asthma in an animal model. Nature 1997; 385:721-5.
20. Dastych J, Hardison MC, Metcalfe DD. Aggregation of low affinity IgG receptors induces mast cell adherence to fibronectin. Requirement for the common FcR γ-chain. J Immunol 1997; 158:1803-9.
21. Schwartz LB, Austen KF, Wasserman SI. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol 1979; 123:1445-50.
22. Yoshikawa H, Nakajima Y, Tasaka K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 1999; 162:6162-70.
23. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13:2905-27.
24. Gao Z, Li BS, Day YJ, Linden J. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 2001; 59:76-82.
25. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13:382-7.
26. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13:400-11.
27. Polosa R, Holgate ST. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 1997; 52:919-23.
28. Marquardt DL, Parker CW, Sullivan TJ. Potentiation of mast cell mediator release by adenosine. J Immunol 1978; 120:871-8.
29. Suzuki H, Takei M, Nakahata T, Fukamachi H. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun 1998; 242:697-702.
30. Hannon JP, Pfannkuche HJ, Fozard JR. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol 1995; 115:945-52.
31. Reeves JJ, Jones CA, Sheehan MJ, Vardey CJ, Whelan CJ. Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Res 1997; 46:180-4.
32. Finnerty JP, Polosa R, Holgate ST. Repeated exposure of asthmatic airways to inhaled adenosine 5′-monophosphate attenuates bronchoconstriction provoked by exercise. J Allergy Clin Immunol 1990; 86:353-9.
33. Jacobson KA. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 1998; 19:184-91.
34. Shneyvays V, Nawrath H, Jacobson KA, Shainberg A. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist. Exp Cell Res 1998; 243:383-97.
35. Barbieri D, Abbracchio MP, Salvioli S. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int 1998; 32:493-504.
36. Blackburn MR, Volmer JB, Thrasher JL et al. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 2000; 192:159-70.
37. Zhong H, Chunn JL, Volmer JB, Fozard JR, Blackburn MR. Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice. J Pharmacol Exp Ther 2001; 298:433-40.